Conversion from sandimmune to neoral at two different dose-ratio in stable renal transplant patients.

被引：0
|
作者：
Gaspari, F
Perico, N
Pisoni, R
Anedda, MF
Signorini, O
Gotti, E
Remuzzi, G
机构：
[1] MARIO NEGRI INST PHARMACOL RES, I-24100 BERGAMO, ITALY
[2] OSPED RIUNITI BERGAMO, BERGAMO, ITALY
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1997年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A3314 / A3314
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients
    Gaston, R
    Alloway, RR
    Gaber, AO
    Rossi, SJ
    Schroeder, TJ
    Irish, WD
    Canafax, DM
    First, MR
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 326 - 327
  • [42] Cyclosporine dose, blood levels, and renal allograft function after conversion from Sandimmune to Neoral.
    Schmouder, RL
    Rossi, SJ
    Henry, SL
    Leichtman, AB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3378 - A3378
  • [43] Case study: Conversion of a liver transplant patient from cyclosporine sandimmune to neoral
    Levy, GA
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2252 - 2253
  • [44] Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: Results from a single center
    Cossu, M
    Satta, R
    Branca, GF
    Pala, PG
    Serra, G
    Satta, RP
    Sorba, G
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1762 - 1763
  • [45] Pharmacokinetic analysis of neoral conversion in pediatric and adult renal transplant recipients with poor absorption of sandimmune
    Pescovitz, MD
    Henson, S
    Bodziak, K
    Book, BK
    Gonin, J
    Jindal, RM
    Leapman, SB
    Milgrom, ML
    Filo, RS
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2165 - 2168
  • [46] Safety and tolerability of CyA microemulsion formulation (Sandimmune Neoral) in stable renal transplant patients after 24 months of treatment
    Offermann, G
    Korn, A
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2204 - 2206
  • [47] Conversion from sandimmune to neoral in pediatric renal transplantation: Effect of patient age.
    Kamal, S
    Marik, J
    Ettenger, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3203 - A3203
  • [48] Safety and tolerability of Sandimmune Neoral vs Sandimmune in de novo renal transplant patients after 24 months' treatment
    Buchholz, B
    Korn, A
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (04) : 2187 - 2188
  • [49] Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients
    Cortinovis, Monica
    Gotti, Eliana
    Trillini, Matias
    Carrara, Fabiola
    Gaspari, Flavio
    Ruggenenti, Piero
    Remuzzi, Giuseppe
    Perico, Norberto
    NEPHRON, 2017, 135 (03) : 173 - 180
  • [50] Conversion from cyclosporine to neoral in stable liver transplant recipients
    Jain, A
    Gadomski, M
    Fung, J
    HEPATOLOGY, 1996, 24 (04) : 191 - 191
12345